Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Abate Kristin sold 53 Karyopharm Therapeutics Inc. shares (Form 4)

Traded May 13 to May 14, 2026 · Filed May 15, 2026

From May 13 to May 14, 2026, Abate Kristin (Chief Accounting Officer) sold 53 Karyopharm Therapeutics Inc. shares at US$9.50 for US$504, leaving 23,801 shares. Filed May 15, 2026 (Form 4).

Sold
53 shares
Price
US$9.50
Value
US$504
Holding after
23,801 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockAward12123,854Direct
May 14, 2026Common StockSale53US$9.5023,801Direct

Source

View original at SEC

Related